JFNIX
Price
$67.37
Change
+$0.24 (+0.36%)
Updated
Jul 25 closing price
Net Assets
4.4B
RYHCX
Price
$86.49
Change
+$0.38 (+0.44%)
Updated
Jul 25 closing price
Net Assets
18.37M
Interact to see
Advertisement

JFNIX vs RYHCX

Header iconJFNIX vs RYHCX Comparison
Open Charts JFNIX vs RYHCXBanner chart's image
Janus Henderson Global Life Sciences I
Price$67.37
Change+$0.24 (+0.36%)
VolumeN/A
Net Assets4.4B
Rydex Health Care C
Price$86.49
Change+$0.38 (+0.44%)
VolumeN/A
Net Assets18.37M
JFNIX vs RYHCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. RYHCX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and RYHCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.4B vs. RYHCX (18.4M). JFNIX pays higher dividends than RYHCX: JFNIX (0.41) vs RYHCX (0.00). JFNIX was incepted earlier than RYHCX: JFNIX (16 years) vs RYHCX (24 years). RYHCX (2.43) is less costly to investors than JFNIX (0.77). RYHCX is a more actively managed with annual turnover of: 236.00 vs. JFNIX (35.00). JFNIX (2500) and RYHCX (2500) have matching initial minimum investment requirements. RYHCX annual gain was more profitable for investors over the last year : -6.47 vs. JFNIX (-14.39). JFNIX return over 5 years is better than : 5.22 vs. RYHCX (-0.44).
JFNIXRYHCXJFNIX / RYHCX
Total Expense Ratio0.772.4032%
Annual Report Gross Expense Ratio0.772.4332%
Fund Existence16 years24 years-
Gain YTD-1.3080.326-401%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B18.4M23,924%
Annual Yield % from dividends0.410.00-
Returns for 1 year-14.39-6.47222%
Returns for 3 years8.973.32270%
Returns for 5 years5.22-0.44-1,189%
Returns for 10 years7.40-11.71-63%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMIDX18.310.19
+1.05%
Brown Advisory Mid-Cap Growth Investor
JGTTX40.99N/A
N/A
JPMorgan Growth Advantage R3
LMRNX33.07N/A
N/A
1919 Socially Responsive Balanced I
MSFLX34.53N/A
N/A
Morgan Stanley Inst Global Franchise L
TRSZX22.64N/A
N/A
T. Rowe Price Mid-Cap Index Z